Grandfield & Dodd, LLC Gilead Sciences, Inc. Transaction History

Grandfield & Dodd, LLC

  • $1.5 Billion
  • Q1 2024

A detailed history of Grandfield & Dodd, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 279,734 shares of GILD stock, worth $18.9 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
279,734
Previous 280,980 0.44%
Holding current value
$18.9 Million
Previous $22.8 Million 9.98%
% of portfolio
1.36%
Previous 1.65%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$71.58 - $87.29 $89,188 - $108,763
-1,246 Reduced 0.44%
279,734 $20.5 Million
Q4 2023

Jan 31, 2024
SELL
$73.27 - $83.09 $7,107 - $8,059
-97 Reduced 0.03%
280,980 $22.8 Million
Q3 2023

Oct 25, 2023
BUY
$73.94 - $80.67 $411,550 - $449,009
5,566 Added 2.02%
281,077 $21.1 Million
Q2 2023

Aug 07, 2023
SELL
$76.01 - $86.7 $214,804 - $245,014
-2,826 Reduced 1.02%
275,511 $21.2 Million
Q1 2023

Apr 28, 2023
BUY
$77.31 - $88.08 $163,974 - $186,817
2,121 Added 0.77%
278,337 $23.1 Million
Q4 2022

Jan 20, 2023
BUY
$62.32 - $89.47 $247,285 - $355,016
3,968 Added 1.46%
276,216 $0
Q3 2022

Nov 03, 2022
BUY
$59.54 - $68.01 $505,196 - $577,064
8,485 Added 3.22%
272,248 $16.8 Million
Q2 2022

Aug 01, 2022
BUY
$57.72 - $65.01 $688,080 - $774,984
11,921 Added 4.73%
263,763 $16.3 Million
Q1 2022

Apr 19, 2022
BUY
$57.92 - $72.58 $494,984 - $620,268
8,546 Added 3.51%
251,842 $15 Million
Q4 2021

Feb 08, 2022
BUY
$64.88 - $73.64 $456,884 - $518,572
7,042 Added 2.98%
243,296 $17.7 Million
Q3 2021

Oct 28, 2021
BUY
$67.69 - $73.03 $899,600 - $970,568
13,290 Added 5.96%
236,254 $16.5 Million
Q2 2021

Jul 28, 2021
BUY
$63.47 - $69.35 $1.29 Million - $1.41 Million
20,344 Added 10.04%
222,964 $15.4 Million
Q1 2021

Apr 22, 2021
BUY
$60.0 - $68.46 $998,400 - $1.14 Million
16,640 Added 8.95%
202,620 $13.1 Million
Q4 2020

Jan 29, 2021
BUY
$56.65 - $64.55 $190,910 - $217,533
3,370 Added 1.85%
185,980 $10.8 Million
Q3 2020

Nov 03, 2020
BUY
$62.1 - $78.08 $246,723 - $310,211
3,973 Added 2.22%
182,610 $11.5 Million
Q2 2020

Jul 24, 2020
SELL
$72.34 - $84.0 $72,918 - $84,672
-1,008 Reduced 0.56%
178,637 $13.7 Million
Q1 2020

May 14, 2020
BUY
$62.63 - $80.22 $349,538 - $447,707
5,581 Added 3.21%
179,645 $13.4 Million
Q4 2019

Feb 07, 2020
BUY
$61.62 - $67.78 $275,749 - $303,315
4,475 Added 2.64%
174,064 $11.3 Million
Q3 2019

Oct 30, 2019
BUY
$62.51 - $69.0 $242,226 - $267,375
3,875 Added 2.34%
169,589 $10.7 Million
Q2 2019

Jul 29, 2019
BUY
$61.87 - $69.38 $514,387 - $576,825
8,314 Added 5.28%
165,714 $11.2 Million
Q1 2019

Apr 26, 2019
BUY
$62.53 - $70.05 $373,304 - $418,198
5,970 Added 3.94%
157,400 $10.2 Million
Q4 2018

Feb 12, 2019
SELL
$60.54 - $79.0 $36,626 - $47,795
-605 Reduced 0.4%
151,430 $9.47 Million
Q3 2018

Nov 02, 2018
BUY
$71.28 - $78.92 $387,050 - $428,535
5,430 Added 3.7%
152,035 $11.7 Million
Q2 2018

Jul 27, 2018
BUY
$64.88 - $75.68 $497,629 - $580,465
7,670 Added 5.52%
146,605 $10.4 Million
Q1 2018

May 04, 2018
BUY
$72.84 - $88.8 $216,116 - $263,469
2,967 Added 2.18%
138,935 $10.5 Million
Q4 2017

Feb 06, 2018
BUY
$71.15 - $83.52 $561,942 - $659,640
7,898 Added 6.17%
135,968 $9.74 Million
Q3 2017

Nov 03, 2017
BUY
$72.11 - $85.47 $9.24 Million - $10.9 Million
128,070
128,070 $10.4 Million

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $84.7B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email